These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3597999)

  • 1. Reduction in sudden death and total mortality by antiarrhythmic therapy evaluated by electrophysiologic drug testing: criteria of efficacy in patients with sustained ventricular tachyarrhythmia.
    Waller TJ; Kay HR; Spielman SR; Kutalek SP; Greenspan AM; Horowitz LN
    J Am Coll Cardiol; 1987 Jul; 10(1):83-9. PubMed ID: 3597999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple monomorphic ventricular tachycardia configurations predict failure of antiarrhythmic drug therapy guided by electrophysiologic study.
    Mitrani RD; Biblo LA; Carlson MD; Gatzoylis KA; Henthorn RW; Waldo AL
    J Am Coll Cardiol; 1993 Oct; 22(4):1117-22. PubMed ID: 8409050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiologic drug testing in patients with malignant ventricular arrhythmias: importance of stimulation at more than one ventricular site.
    Morady F; Hess D; Scheinman MM
    Am J Cardiol; 1982 Nov; 50(5):1055-60. PubMed ID: 7137032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of a serial electropharmacologic study in survivors of a cardiac arrest secondary to ventricular tachycardia or ventricular fibrillation].
    Raviele A; Di Pede F; Delise P; Piccolo E
    G Ital Cardiol; 1984 Sep; 14(9):644-54. PubMed ID: 6510619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The response to procainamide during electrophysiologic study for sustained ventricular tachyarrhythmias predicts the response to other medications.
    Waxman HL; Buxton AE; Sadowski LM; Josephson ME
    Circulation; 1983 Jan; 67(1):30-7. PubMed ID: 6847803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with coronary artery disease as assessed by electrophysiologic studies.
    Rae AP; Greenspan AM; Spielman SR; Sokoloff NM; Webb CR; Kay HR; Horowitz LN
    Am J Cardiol; 1985 Jun; 55(13 Pt 1):1494-9. PubMed ID: 3890509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained ventricular tachycardia in patients with idiopathic dilated cardiomyopathy: electrophysiologic testing and lack of response to antiarrhythmic drug therapy.
    Poll DS; Marchlinski FE; Buxton AE; Doherty JU; Waxman HL; Josephson ME
    Circulation; 1984 Sep; 70(3):451-6. PubMed ID: 6744550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of electrophysiologic testing in patients with nonsustained ventricular tachycardia: prognostic and therapeutic implications.
    Klein RC; Machell C
    J Am Coll Cardiol; 1989 Jul; 14(1):155-61; discussion 162-3. PubMed ID: 2738260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study.
    Giorgberidze I; Saksena S; Krol RB; Munsif AN; Kolettis T; Mathew P; Varanasi S; Prakash A; Delfaut P; Lewis CB
    Am J Cardiol; 1997 Sep; 80(5B):3F-9F. PubMed ID: 9291444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Slowing of ventricular tachycardia as a possible endpoint for serial drug testing at electrophysiological study.
    Handlin LR; Brodine WN; Gibbs H; Vacek JL
    Pacing Clin Electrophysiol; 1992 Jun; 15(6):864-9. PubMed ID: 1376898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Graded criteria to assess the effectiveness of anti-arrhythmia therapy in patients with ventricular tachyarrhythmia by serial electrophysiological testing].
    Borggrefe M; Breithardt G
    Z Kardiol; 1986 Feb; 75(2):70-9. PubMed ID: 3705680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiologic testing and follow-up of patients with aborted sudden death.
    Eldar M; Sauve MJ; Scheinman MM
    J Am Coll Cardiol; 1987 Aug; 10(2):291-8. PubMed ID: 3598002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiarrhythmic drug exacerbation of ventricular tachycardia inducibility during electrophysiologic study.
    Sager PT; Perlmutter RA; Rosenfeld LE; Batsford WP
    Am Heart J; 1992 Apr; 123(4 Pt 1):926-33. PubMed ID: 1550002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiologic evaluation of antiarrhythmic therapy for ventricular tachyarrhythmias.
    Kuchar DL; Garan H; Ruskin JN
    Am J Cardiol; 1988 Oct; 62(12):39H-45H. PubMed ID: 3052008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenytoin in the treatment of inducible ventricular tachycardia: results of electrophysiologic testing and long-term follow-up.
    Epstein AE; Plumb VJ; Henthorn RW; Waldo AL
    Pacing Clin Electrophysiol; 1987 Sep; 10(5):1049-57. PubMed ID: 2444929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study.
    Klein LS; Fineberg N; Heger JJ; Miles WM; Kammerling JM; Chang MS; Zipes DP; Prystowsky EN
    Am J Cardiol; 1988 May; 61(13):1024-30. PubMed ID: 3364357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators.
    Mason JW
    N Engl J Med; 1993 Aug; 329(7):445-51. PubMed ID: 8332149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiologic assessment of antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with dilated cardiomyopathy.
    Rae AP; Spielman SR; Kutalek SP; Kay HR; Horowitz LN
    Am J Cardiol; 1987 Feb; 59(4):291-5. PubMed ID: 3544793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiologic testing in the management of survivors of out-of-hospital cardiac arrest.
    Morady F; Scheinman MM; Hess DS; Sung RJ; Shen E; Shapiro W
    Am J Cardiol; 1983 Jan; 51(1):85-9. PubMed ID: 6849269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of successful suppression of sustained ventricular tachyarrhythmias by serial drug testing from data derived at the initial electrophysiologic study.
    Kuchar DL; Rottman J; Berger E; Freeman CS; Garan H; Ruskin JN
    J Am Coll Cardiol; 1988 Oct; 12(4):982-8. PubMed ID: 3047198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.